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Polo-like kinase-1 (Plk1) is phosphorylated on Thr210 for activation during mitosis. Here, we inves-
tigated the question of which kinase(s) is the speciﬁc upstream kinase of mitotic Plk1. Upstream
kinases of Plk1 were puriﬁed from mitotic cell extracts through column chromatography proce-
dures, and identiﬁed by mass spectrometry. Candidates for Plk1 kinase included p21-activated
kinase, aurora A, and mammalian Ste20-like kinases. Immunoprecipitates of these proteins from
mitotic cell extracts phosphorylated Plk1 on Thr210. Even if the activity of Aurora A was blocked
with a speciﬁc inhibitor, Plk1 phosphorylation still occurred, suggesting that function of Plk1 could
be controlled by these kinases for proper mitotic progression, as well as by Aurora A in very late G2
phase for the beginning of mitosis.
Structured abstract:
MINT-7996332: PAK1 (uniprotkb:Q13153) physically interacts (MI:0915) with PLK1 (uniprotkb:P53350)
by pull down (MI:0096)
MINT-7996345: PAK3 (uniprotkb:O75914) physically interacts (MI:0915) with PLK1 (uniprotkb:P53350)
by pull down (MI:0096)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mammalian Plk1 is a mitosis-speciﬁc kinase whose activity
peaks at the onset of mitosis [1,2]. Although expression of Plk1
peaks during both G2 phase and mitosis, the kinase activity of mi-
totic Plk1 is higher than that of interphasic Plk1. Plk1 activity grad-
ually decreases as the mitotic phase proceeds, but persists longer
than Cdc2 kinase activity associated with cyclin B [2]. Kinase activ-
ity of Plk1 is apparently regulated by posttranslational modiﬁca-
tion [3,4]. During mitosis, Plk1 is phosphorylated and migrates
more slowly on electrophoresis. Activation of Plk1 requires
phosphorylation of a conserved threonine residue (Thr-210) in
the T-loop of the Plk1 kinase domain [5]. Phosphatase treatment
increases mobility, and reduces the activity of the enzyme. Entry
into mitosis is controlled by activation of Cdc2, and this activity
is regulated directly by mitotic cyclin B and phosphatase Cdc25.
Activation of Plk1 coincides with increased Cdc2-cyclin B activity
in synchronized cells; however, the question of whether or notchemical Societies. Published by Edirect activation of Plk1 by Cdc2-cyclin B is still controversial
[2,6–8]. On the contrary, Plx1 (Plk1 homolog in Xenopus) directly
phosphorylates and activates Cdc25C, which activates Cdc2-cyclin
B during progesterone-induced oocyte maturation [9]. Microinjec-
tion of a constitutively active Plx1 mutant into Xenopus oocytes di-
rectly activates both Cdc25C and Cdc2 without hormone treatment
[10]. In addition to Plx1, Cdc2-cyclin B activity is regulated indi-
rectly by Plk1 and aurora A in mammalian systems [11–14]. Qian
et al. originally reported that an enzyme puriﬁed from Xenopus
egg extracts appears to be the major upstream kinase responsible
for phosphorylation and activation of Plx1 [15]. Microinjection of
this enzyme, denoted as xPlkk1, into Xenopus oocytes accelerates
the time of Plx1 activation as well as the transition from G2 phase
to mitosis during oocyte maturation. xPlkk1 shows high sequence
homology to Ste20-like protein kinases, and the kinase domain of
xPlkk1 is closely related to that of the Ste20-like enzymes, ste20-
like kinase (Slk) [16] and lymphocyte-oriented kinase [11,17]. Slk
phosphorylates and activates Plk1 throughout the G2 phase of
the mammalian cell cycle [16]. More recently, results from other
experiments have indicated that Plk1 activation occurs several
hours before the start of the mitotic phase, and requires aurora
A-dependent phosphorylation of Thr-210 [18,19]. Aurora A activity
for Plk1 activation is enhanced by Bora, which is a cofactor forlsevier B.V. All rights reserved.
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dominant-negative mutant, and induces pre-anaphase arrest and
cytokinesis failure [4,8]. A polo-box mutant of Plk1, which has ki-
nase activity, but defects on subcellular localization, is capable of
abolishing its biological activity in vivo [21,22]. These data from
genetic and biochemical experiments suggest that the polo-
box of Plk1 plays an important role in localization of Plk1 itself
and in downstream targeting, especially for its spatial distribution
and physical interaction with substrates, and that Plk1 is a pivotal
regulator of various cell cycle-related progression in eukaryotic
cells. In addition, the activity of Plk1 is controlled by its own
conformational change. When the Thr-210 residue is not phos-
phorylated in G2 phase cells, the PBD interacts with the kinase do-
main and inhibits kinase activity [4,23]. This inhibitory effect
disappears in mitotic Plk1 through Thr-210 phosphorylation. Bora
can directly interact with Plk1 in early G2 phase, and Plk1
phosphorylation is accessed by Aurora A in G2 phase. Activity of
Plk1 is maintained by Aurora A in a Bora-dependent manner
[18,19]. However, Plk1 is phosphorylated in early mitosis rather
than in interphase, and this phosphorylation continues until the
end of mitosis, even until Plk1 is degraded. In this study, we have
identiﬁed upstream kinases for activation of Plk1 from mitotic cell
extracts. Through the original column chromatographic puriﬁca-
tion, we identiﬁed several candidates for the Plk1 regulator for
activation of Plk1, which can phosphorylate on the Thr-210 residue.2. Materials and methods
2.1. Antibodies and reagents
The following antibodies were used in this study: mouse mono-
clonal antibodies against FLAG (Sigma–Aldrich), HA (Roche), Plk1
(Zymed), and phospho-Plk1 (pT210) (Pharmingen); rabbit poly-
clonal antibodies against Cyclin B1 (Santa Cruz), Aurora A (Santa
Cruz), and Pak1 (Santa Cruz); goat polyclonal antibodies against
Pak2 (Santa Cruz), Pak3 (Santa Cruz), and Actin (Santa Cruz).
Mimosine and nocodazole were obtained from Sigma–Aldrich.
VX680 was purchased from LCLabs.2.2. Cell culture, synchronization, and transfection
Mouse mammary carcinomas FT210 and HeLa cells were main-
tained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (Hyclone) in a humidiﬁed
incubator at 33 and 37 C, respectively. For G2 phase andmitotic ar-
rest, FT210 cells were incubated at 39 C in the absence of and in the
presenceof nocodazole (100 ng/ml) for 16 h, respectively [24]. To in-
hibit Aurora A, HeLa cells were treated simultaneously with both
nocodazole and VX680 (500 nM) for 8 h [25]. For synchronization,
cells were treated with thymidine (2 mM) for 16 h; thymidine was
released for 9 h, followed by 18 h thymidine arrest [26]. Unsynchro-
nous cells were treated with Okadaic acid (1 lM) for 1 h as a phos-
phatase inhibitor [27]. Transfection of DNA was performed by the
standard calcium chloride method with modiﬁcation [4,28].2.3. Expression of recombinant Plk1 in an insect cell system
To generate recombinant baculovirus for protein expression in
insect cells, DNA constructs were cloned into the pAcGHLT-B vec-
tor (PharMingen), and transfected into Sf9 cells with BaculoGold
(PharMingen). Sf9 cells were maintained at 27 C in TNM-FH Insect
Medium (SAFC Biosciences, Kansas, USA). Supernatant containing
recombinant virus was collected after 5 days, and used for viral
ampliﬁcation. Recombinant proteins of the wild type Plk1 andK82M mutant were expressed in High 5 cells in EX-CELL 405 med-
ium (SAFC Biosciences).
2.4. Preparation of mammalian cell lysates
FT210 Cells were lysed in NP-40 lysis buffer (0.5% Nonidet P-40,
50 mMHepes, pH 7.4, 150 mMNaCl, 1 mMDTT, 5 mM EGTA, 1 mM
EDTA, 20 mM NaF, 20 mM b-glycerophosphate, 0.5 mM Na3VO4,
20 mM p-nitrophenyl phosphate) supplemented with protease
inhibitors. Cell extracts were centrifuged at 15 000g for 20 min,
and supernatants were recovered and used as a source for puriﬁca-
tion of Plk1 upstream kinase. See Supplementary data for more de-
tailed procedures.
2.5. Protein kinase assay
The kinase reaction was carried out as described [5]. Brieﬂy, ki-
nase activitywasmeasured in a kinase buffer solution (50 mMTris–
Cl, pH 7.4, 10 mM MgCl2, 1 mM DTT, 2 mM EGTA, 0.5 mM Na3VO4,
20 mM p-nitrophenyl phosphate) supplemented with 100 lM ATP
and 10 lCi of [c-32P]ATP (1 Ci = 37 GBq) at 30 C for 30 min.
2.6. Puriﬁcation of Plk1 upstream regulators from mitotic FT210 cell
lysates
See Supplementary data 2 for more detailed procedures.
2.7. Identiﬁcation of Plk1 upstream regulators by mass spectrometry
See Supplementary data 2 for more detailed procedures.3. Results
3.1. Plk1 is phosphorylated on Thr-210 by mitotic cell extracts
Mouse mammary carcinoma FT210 cells were synchronized in
G2 phase by incubation at a non-permissive temperature of
39 C, and in mitosis by treatment with nocodazole for 16 h,
respectively. Under these culture conditions at 39 C, Cdc2 kinase
was inhibited, and cells were efﬁciently arrested in G2 phase (Sup-
plementary data 1A) [24]. To examine the existence of upstream
regulators in mitotic cell lysates, we performed an in vitro kinase
assay with cell lysates as a source of upstream kinase of Plk1 and
[c-32P]ATP. Results of the kinase assay showed phosphorylation
of Plk1 K82M mutant by addition of mitotic cell lysates (Fig. 1A,
lane 2 in panel 32P), but not by addition of G2-phase cell lysates
(Fig. 1A, lane 1 in panel 32P). To investigate the question of whether
or not this phosphorylation occurs on the Thr-210 residue, we per-
formed western blot analysis of Plk1 constructs transfected in mi-
totic cells using a phospho-speciﬁc Plk1 antibody on Thr-210
(pT210). FLAG-tagged Plk1 mutant, K82M, was transfected into mi-
totic cells, and immunoprecipitated using an anti-FLAG antibody.
K82Mmutant was detected by pT210 antibody, whereas T210 mu-
tants, T210V and T210D were not detected by this antibody (Sup-
plementary data 1B, panel pT210). Indeed, when recombinant
K82M was phosphorylated by xPlkk1 in vitro, this construct was
detected by an anti-pT210 antibody (Supplementary data 1C, lane
2 in panel pT210). Thus, we used the recombinant K82Mmutant as
a substrate in the kinase assay for puriﬁcation of the Plk1 upstream
kinase(s) responsible for Thr-210 speciﬁc phosphorylation.
3.2. Puriﬁcation of Plk1 kinase(s) from mitotic FT210 cell lysates
Based on Plk1 phosphorylation using mitotic cell lysates, we
performed a protein puriﬁcation experiment to purify the up-
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Fig. 1. Process for puriﬁcation of protein kinase(s) containing Plkk activity. (A) Plk1
phosphorylation on Thr-210 using mitotic cell lysates. Recombinant kinase-dead
mutant (K82M) of Plk1 was used as a substrate for the plkk assay. K82M protein
was incubated with G2 phase (lane 1) or mitotic (lane 2) cell lysates as a Plkk
source, and the in vitro kinase assay was then performed. Phosphorylated Plk1 was
detected by autoradiography. The amount of recombinant proteins used was shown
by Coomassie staining (CBB). (B) The supernatant of ammonium sulfate fraction-
ation was loaded on DEAE-Sepharose (a), Hydroxyapatite (b), and Mono Q (c)
columns. Fractions were assayed for phosphorylation of K82M in the presence of
[c-32P]ATP and separated on SDS–PAGE (d). Protein amounts of each fraction
were estimated by Coomassie staining and Plkk activity was detected by
autogradiography.
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of Plk1, termed polo-like kinase-1 kinase(s) (Plkks). We used ki-
nase-dead mutant K82M as a substrate in a radio-labeled kinase
assay. In a suspension culture of FT210 cells, a total of 7–
8  1010 cells were synchronized in prometaphase. Column chro-
matographic processes were used in puriﬁcation of Plk1 kinase(s)
from cell lysate, as described in Supplementary data 2. The sam-
ple was loaded onto an ion-exchange column (DEAE-Sepharose),
and adsorbed proteins were eluted in a linear gradient of 0–
1.0 M NaCl. Each fraction was applied in the in vitro kinase assay
with [c-32P]ATP as a source of Plk1 upstream kinase. Active frac-
tions with Plkk activity (86–91 fractions) were pooled (Fig. 1B, a
and Supplementary data 2A) and loaded onto a Hydroxyapatite
column. In a linear gradient of 0–1.0 M phosphate, the adsorbed
proteins were eluted, and fractions 72–78 were pooled (Fig. 1B,
b and Supplementary data 2B). Following Sephacryl S-200 column
chromatography, elutes were subjected to Mono Q column chro-
matography. Finally, an active fraction (fraction No. 39) with ki-
nase activity was obtained after in vitro Plk1 (Fig. 1B, c &
Supplementary data 2C). Proteins of this ﬁnal fraction were sepa-
rated on SDS–PAGE, and their proﬁles were detected by Coomas-
sie staining (Fig. 1B, d).3.3. Identiﬁcation of putative Plk1 upstream kinase(s) by proteomic
analysis of mass spectrometry
Proteins in the active fraction obtained from the Mono Q col-
umn were analyzed by electrophoresis (Fig. 1B, d) and all of the
protein bands were applied on MALDI-TOF spectrometry, as de-
scribed in Supplementary data 2. Through molecular mass analysis
and Mascot searches of the resulting Lys-C fragments, several
known protein kinases were obtained as candidates for upstream
kinase of Plk1 (Fig. 2A). Representative candidates included p21-
activated kinases (Paks), mammalian Ste-20 like kinases (Msts),
and aurora A. We investigated the question of whether or not these
kinases phosphorylated Plk1 on Thr-210. Each protein kinase was
immunoprecipitated by each speciﬁc antibody from prometapha-
sic cell lysates, and used in the kinase assay as a source of Plkk. Re-
combinant Plk1 K82M, which was phosphorylated on Thr-210, was
detected by anti-pT210-Plk1 antibody in western analysis. When
immunoprecipitants of endogenous Pak1, Pak3, and aurora A ki-
nase were used as Plkk sources, phospho-T210 signals were rela-
tively strong in comparison with protein amounts (Fig. 2B, panels
a-pT210). These results indicated that Paks, Msts, and aurora A ki-
nase are able to phosphorylate Thr210 of Plk1 in mitotic cells.
3.4. Thr210 phosphorylation of Plk1 still occurred under conditions of
aurora A inhibition
Occurrence of Plk1 activation in late G2 phase requiring aurora
A kinase-dependent phosphorylation of Thr-210, and enhance-
ment of aurora A activity for Plk1 activation by Bora have recently
been reported [18,19]. However, Plk1 phosphorylation and activa-
tion need to be durable until the end of mitosis for mitosis-speciﬁc
functions as well as for initiation of mitosis. In addition, because
aurora A was screened out as a mitotic Plkk in our experiment, aur-
ora A may possibly act as an upstream kinase of Plk1 during mito-
sis as well as G2 phase. To investigate the question of whether or
not other kinase(s) are involved in Plk1 phosphorylation and acti-
vation during mitotic progression, we evaluated Thr210 phosphor-
ylation of Plk1 in the absence of aurora A kinase activity at G2/M
transition. For inhibition of aurora A kinase, before the start of
mitosis and during mitosis, HeLa cells were treated with 100 ng/
ml of nocodazole and 500 nM of VX680 for 16 h. By using the
immunoprecipitates of aurora A, kinase activity of aurora A was
tested by in vitro kinase assay using histone H3 as a substrate,
and its activity decreased substantially in mitotic cells treated with
inhibitor in comparison with that in untreated mitotic cells
(Fig. 3A, lane 2 in panel 32P-H3). Under these conditions, Plk1 phos-
phorylation on Thr-210 decreased, but still remained in mitotic
cells treated with VX680 (Fig. 3A, lanes 2 in a-Plk and a-pT210).
Although the phosphor-MPM2 signals were decreased (Fig. 3B,
lane 3) as compared with those in nocodazole treatment (Fig. 3B,
lane 1), mitotic cells were still remained under the condition of
aurora A inhibition. Repeatedly, inhibitory phosphor-Cdc2 signals
were not much increased under the condition of aurora A inhibi-
tion (Fig. 3B, lane 2). These data suggested that another upstream
regulator(s) of Plk1 may act under conditions of elimination of aur-
ora A kinase activity.
3.5. P21-activated protein kinases as an upstream kinase of Plk1
In addition to Plk1 Thr-210 phosphorylation by Paks (Fig. 2B),
we examined protein expression levels during the cell cycle. To
determine whether or not Paks were expressed in a fashion similar
to that of Plk1, HeLa cells were arrested in G1/S boundary, and then
harvested every 1–2 h after release, and endogenous proteins were
determined by western analysis. Flow cytometry analysis revealed
that 43% of cells were in G2/M phase at 6 h release, and that G2/M
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Fig. 2. Identiﬁcation of puriﬁed protein kinases by mass spectrometry and proteomic sequence analysis. (A) Final fractions containing active Plkk from the Mono Q column
were pooled, and the immobilized proteins were reduced, S-carboxymethylated, digested, and then applied to MALDI-TOF mass spectrometry. Sequence identiﬁcation was
performed by data acquisition and processing using Voyager software version 5.1 and Data Explorer software version 4.0 (Applied Biosystems). (B) Putative upstream
regulators of Plk1 phosphorylate Plk1 on the Thr-210 residue. Endogenous protein kinases were immunoprecipitated using proper antibodies from mitotic HeLa cells, and
applied to an in vitro kinase assay as kinase sources (IP). Results from the kinase assay showed that recombinant Plk1 K82M proteins were puriﬁed from insect cells and used
as substrate (K82M). Without addition of [c-32P]ATP, Plk1 phosphorylation was detected by a phospho-T210 antibody (a-pT210).
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expected, Plk1 showed gradual accumulation in G2 phase, and
peaked during mitosis, and then decreased during exit from mito-
sis (Fig. 4A, panel a). Pak1 and Pak3 showed cell cycle-dependent
accumulation in a fashion similar to that of Plk1 and cyclin B1
expression (Fig. 4A, panels b, d and e). Next, we conducted an
in vitro pull-down assay using GST-Pak1 and GST-Pak3 with mito-
tic cell extracts. In this experiment, both GST-Pak1 and GST-Pak3
were bound to mitotic Plk1 (Fig. 4B, lanes 2 and 3 in upper panel),
suggesting that Pak1/3 could be upstream regulators of Plk1. When
immunoprecipitates of Paks were added in the in vitro kinase as-
say, kinase activity of Plk1 increased (Fig. 4C, lanes 2 and 3 in upper
panel). Because casein was phosphorylated by Paks, recombinant
TCTP was used for detection of Plk1 speciﬁc activity [27]. As ex-
pected, TCTP was not phosphorylated by Paks (Fig. 4D, lanes 3
and 4 in upper panel). We performed an in vitro kinase assay using
recombinant GST-Pak1/3 proteins puriﬁed from bacteria to rule
out contaminants. The phosphorylation on Thr-210 of Plk1 by
GST-Pak1 and -Pak3 were detected by anti-phospho-T210 anti-
body (Fig. 4E, lane 2 and 3 in upper panel).
3.6. Mammalian Ste20-like kinases as upstream kinases of Plk1
Mst1 and Mst2 have been cloned as homologs of Ste20 and are
known as stress-responsive protein kinases [29,30]. To investigate
the question of whether or not Mst kinases activate Plk1, as well as
phosphorylation on Thr-210 (Fig. 2B), HA-tagged Mst1 and Mst2
were expressed ectopically in mitotic HeLa cells, and were then
immunoprecipitated with an anti-HA antibody. Results of thein vitro kinase assay with [c-32P]ATP showed activation of Plk1
by Mst kinases (Fig. 5A, lanes 5 and 6 in upper panel). Because
Plk1 activation by Mst1 was stronger than that by Mst2, Plkk activ-
ity of Mst1 was analyzed by further experiments. Expression of
endogenous Mst1 kinase showed a slight increase in mitotic cells
(Fig. 5, B and C in upper panels), in which Plk1 was highly phos-
phorylated (Fig. 5B, lane 3 in middle panel). Moreover, Mst1 kinase
activity was increased by treatment with okadaic acid, which is a
phosphatase inhibitor, in a pattern similar to that of xPlkk1
(Supplementary data 3, lane 2 in middle panel).
4. Discussion
In mammalian cells, Plk1 activity is increased from the start of
mitosis until the end of mitosis. Although transcriptional regula-
tion of Plk1 expression may be a dominant factor in Plk1 function,
the speciﬁc activity of Plk1 has previously been demonstrated to
increase during mitotic progression due to phosphorylation
[3,31], suggesting that cell cycle-regulated expression of Plk1
protein is necessary, but not sufﬁcient for increased Plk1 activity
in mitosis. Plk1 activation is induced by phosphorylation on
Thr-210 by an upstream kinase of Plk1, which is denoted as Plkk [5].
xPlkk1, which can phosphorylate and activate Plx1, has previously
been puriﬁed from unfertilized Xenopus eggs, and activates Plx1
during oocyte maturation [15]. Using information on sequence
homology with xPlkk1, Slk had been identiﬁed in mammalian
cells; however, the authors claimed involvement of other kinase(s)
[16]. Two noted studies have recently reported on interaction of
Bora protein with Plk1 and aurora A in early G2 phase, providing
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(C). (E) Thr-210 phosphorylation of Plk1 by recombinant Pak1/3.
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is opened by Bora in late G2 phase, and phosphorylation of Plk1
can occur by aurora A [18,19]. Although phosphorylation and acti-
vation of Plk1 must occur in late G2 phase for beginning mitosis, its
activation should be maintained through mitotic progression for
proper function of Plk1. By treatment with VX680 before mitosis,
kinase activity of aurora A showed a substantial decrease when
compared to controls (Fig. 3, lane 2 in panel 32P-H3). Under these
conditions, Plk1 phosphorylation on Thr-210 remained in mitotic
cells treated with VX680 in comparison with that in untreated cells
(Fig. 3, lanes 2 in a-Plk and a-pT210). These data suggested that
other upstream regulator(s) of Plk1 may exist and may phosphor-
ylate Plk1 in elimination of aurora A activity. By performing tradi-
tional protein puriﬁcation and proteomic analysis, we identiﬁed
several protein kinases that contain Plk1 kinase activity frommito-
tic cell lysates. Because aurora A was identiﬁed as Plkk in our
experiment in coincidence with previous reports [18,19], our ap-
proach was reasonable for screening of Plkks. In our approach,
Ste20-like kinases homologous with Xenopus Plkk1, such as
Mst1/Krs2 and Mst2/Krs1, were identiﬁed. These kinases are
known as ubiquitous stress-responsive protein kinases [29,30]. In
particular, Mst1 kinase phosphorylated and activated Plk1, and
was activated by inhibition of phosphatases, suggesting that
Mst1 activity may be regulated by phosphorylation in a fashion
similar to that of xPlkk1. Although mitotic functions of Mst1/2 in
association with Plk1 were not clear, Plk1 could be involved in
stress-response in a different mechanism from that of a mitosis-
dependent manner. P21-activated kinases (Paks) are serine/threo-
nine kinases that function as downstream regulators for variousoncogenic signaling pathways. They are also likely to be involved
in mitotic progression. Phosphorylation and activation of Pak1
are known to occur in a cell cycle-dependent manner, and are
especially increased before chromatin condensation [32]. Pak1
also localizes to spindle poles, spindle midbody, and, ﬁnally, the
contractile ring during cytokinensis in a similar pattern of Plk1
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Fig. 5. Mammalian STE20-like kinases as an upstream kinase of polo-like kinase 1.
(A) Activation of Plk1 by Mst1 and Mst2. Wild type Plk1 was puriﬁed from insect
cells (His-Plk1), and used for the kinase assay. For quantiﬁcation of Plk1 activity,
casein was used as a Plk1 speciﬁc substrate (32P-CS). HA-tagged Mst1 and Mst2
were immunoprecipitated, and used as a Plkk source. (lanes 1–3) Kinase assay
without Plk1; (lanes 4–6) kinase assay with Plk1; (lanes 1 and 4) Casein
phosphorylation without HA-Msts; (lanes 2 and 5) casein phosphorylation with
HA-Mst2; (lanes 3 and 6) casein phosphorylation with HA-Mst1. (B and C) Mst1
expression showed a slight increase in mitotic cells, in which Plk1 was highly
phosphorylated. Cells were synchronized in G1/S phase and released, as mentioned
in the Section 2. a-Mst1, endogenous Mst1; a-Plk1, endogenous Plk1.
4304 J.-H. Ji et al. / FEBS Letters 584 (2010) 4299–4305localization. According to our data, Pak1/a and Pak3/bwere expressed
in a cell cycle-dependent manner in a fashion similar to that of Plk1
(Fig. 4A). Moreover, treatment with Paks resulted in increased
phosphorylation on Plk1 Thr-210 and activation of Plk1 through di-
rect interaction (Fig. 4B and C). Because Pak1 activity is maintained
throughout mitotic progression for its own functions, we could
easily imagine that Pak1 regulated Plk1 during mitosis. However,
although Plk1 was phosphorylated and activated by Pak1, the hier-
archy of their interaction was still ambiguous. During mitotic pro-
gression, activation of aurora A is dependent on phosphorylation
by Pak1, and Pak-mediated activation results in accumulation of
aurora A for centrosome formation [33]. Conversely, the aurora
A/Bora complex has been reported to be a very potent upstream ki-
nase of Plk1 in late G2 phase. More recently, Maroto et al. reported
that Pak1 is required for mitotic progression and that it regulates
Plk1 [34]. Regulatory mechanisms among Pak1, aurora A, and
Plk1 need to be investigated in future studies. The Plkk potential
of Map kinase has been reported by Tang and his colleagues. Phos-
phorylated p38 and MAP kinase-activated protein kinase 2 (MK2)
are colocalized with Plk1 to the spindle poles during prophase
and metaphase, and that MK2 directly phosphorylates Ser326 of
Plk1 [35]. Additional experiments on MAPK1 and PKCiota as up-
stream activators of Plk1 will be performed in near future. We
are still considering the question of why involvement of other up-
stream kinase(s) is required in mitotic progression. Aurora A/Bora
phosphorylates Plk1 in late G2 phase, when Plk1 expression is rel-
atively high. By this initial phosphorylation on Thr-210, Plk1 struc-
ture is changed to an ‘open structure’. Then, for maintenance of
kinase activity, Plk1 might be phosphorylated continuously on
the same residue by other upstream kinase(s), such as Paks and
Mst1/2. For this reason, Plk1 appears to be phosphorylated in the
absence of aurora A activity (Fig. 3). In summary, to investigate
the question of whether or not other upstream regulator(s) ofPlk1 are present in mammalian cells, we have puriﬁed several
protein kinases, which have Plk1 phosphorylation activity, by col-
umn chromatographic procedures and proteomic analysis. Paks
and Msts directly phosphorylated the Plk1 Thr-210 residue, and
activity of Plk1 was enhanced. The roles of each Plkk candidate
and regulatory mechanism will be studied in more detail in the
future.
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